BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8123580)

  • 1. British Photodermatology Group guidelines for PUVA.
    Br J Dermatol; 1994 Feb; 130(2):246-55. PubMed ID: 8123580
    [No Abstract]   [Full Text] [Related]  

  • 2. [The pharmacokinetic and toxicologic profile of 8-methoxypsoralen. The basis for safe and effective PUVA therapy].
    Schmid J; Brickl R; Koss FW
    Derm Beruf Umwelt; 1988; 36(6):177-85. PubMed ID: 3069432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photochemotherapy in psoriasis and other skin diseases.
    Adrian RM
    Am Fam Physician; 1981 May; 23(5):95-100. PubMed ID: 7234635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultraviolet phototherapy for cutaneous diseases: a concise review.
    Vangipuram R; Feldman SR
    Oral Dis; 2016 May; 22(4):253-9. PubMed ID: 26464123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
    Shephard SE; Panizzon RG
    Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo.
    McNeely W; Goa KL
    Drugs; 1998 Oct; 56(4):667-90. PubMed ID: 9806110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis from 5-methoxypsoralen occurring in a patient with previous flucloxacillin hepatitis.
    Stephens RB; Cooper A
    Australas J Dermatol; 1999 Nov; 40(4):217-9. PubMed ID: 10570561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of psoriasis with a new micronized 5-methoxypsoralen tablet and UVA radiation.
    Aubin F; Makki S; Humbert P; Muret P; Agache P
    Arch Dermatol Res; 1994; 286(1):30-4. PubMed ID: 8141609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The occurrence of vitiligo after psoralens and ultraviolet a therapy.
    Todes-Taylor N; Abel EA; Cox AJ
    J Am Acad Dermatol; 1983 Oct; 9(4):526-32. PubMed ID: 6630615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photochemotherapy beyond psoriasis.
    Honig B; Morison WL; Karp D
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):775-90. PubMed ID: 7929924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The risks of photochemotherapy (author's transl)].
    Stüttgen G; Kentsch V; Schalla W; Schneider L
    Z Hautkr; 1981 Nov; 56(21):1379-99. PubMed ID: 6458954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective review of PUVA therapy at the National Skin Centre of Singapore.
    Tran D; Kwok YK; Goh CL
    Photodermatol Photoimmunol Photomed; 2001 Aug; 17(4):164-7. PubMed ID: 11499537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
    Weber F; Schmuth M; Sepp N; Fritsch P
    Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bath PUVA and psoriasis: is a milder treatment a worse treatment?
    Delrosso G; Bornacina C; Farinelli P; Bellinzona F; Leigheb G; Colombo E
    Dermatology; 2008; 216(3):191-3. PubMed ID: 18182808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems posed by the therapeutic use of photosensitizers in dermatology].
    Beani JC; Amblard P; Reymond JL
    Biochimie; 1986 Jun; 68(6):905-12. PubMed ID: 2944547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
    Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
    Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance thin-layer chromatographic determination of 5-methoxypsoralen in serum from patients.
    Mignot B; Guillaume Y; Makki S; Murret E; Cavalli E; Truong TT; Thomassin M; Guinchard C
    J Chromatogr B Biomed Sci Appl; 1997 Oct; 700(1-2):283-5. PubMed ID: 9390742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral methoxsalen photochemotherapy of psoriasis and mycosis fungoides.
    Parrish JA; LeVine MJ; Fitzpatrick TB
    Int J Dermatol; 1980 Sep; 19(7):379-86. PubMed ID: 6998879
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study.
    Stern RS; Nichols KT
    J Pediatr; 1996 Dec; 129(6):915-7. PubMed ID: 8969737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.